During the corresponding time, Avricore Health Inc recorded a revenue increase by 79.01 % year on year, While revenue at the Avricore Health Inc 's corporate clients
Avricore Health Inc's Comment on Sales, Marketing and Customers
The Company operates in pharmacy-led healthcare markets in Canada and the United Kingdom, focusing on chronic disease prevention and management through devices such as HealthTab™. Its key customers and market segments include Shoppers Drug Mart locations in Canada, community pharmacies in the UK—representing over half of the country's 12,000 pharmacies—and NHS programs like Pharmacy First. The Company has collaborated with Barts Heart Centre, UCL Partners, and HEART UK on a study, and has a reseller agreement with Abbott Rapid Diagnostics UK & Ireland for Afinion™ 2 devices. The UK government and NHS are significant supporters of pharmacy-led services, investing in initiatives aimed at early detection of cardiovascular disease and diabetes, reducing pressure on general practitioners, and improving care accessibility. The Company is expanding deployments of HealthTab™, integrating with NHS digital systems, and pursuing new partnerships and grants to increase its presence in the UK market.
Avricore Health Inc’s Comment on Sales, Marketing and Customers
The Company operates in pharmacy-led healthcare markets in Canada and the United Kingdom, focusing on chronic disease prevention and management through devices such as HealthTab™. Its key customers and market segments include Shoppers Drug Mart locations in Canada, community pharmacies in the UK—representing over half of the country's 12,000 pharmacies—and NHS programs like Pharmacy First. The Company has collaborated with Barts Heart Centre, UCL Partners, and HEART UK on a study, and has a reseller agreement with Abbott Rapid Diagnostics UK & Ireland for Afinion™ 2 devices. The UK government and NHS are significant supporters of pharmacy-led services, investing in initiatives aimed at early detection of cardiovascular disease and diabetes, reducing pressure on general practitioners, and improving care accessibility. The Company is expanding deployments of HealthTab™, integrating with NHS digital systems, and pursuing new partnerships and grants to increase its presence in the UK market.
Sources:
Avricore Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Avricore Health Inc’s corporate clients.
For your research, we’ve provided 9 tables on Avricore Health Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
51.96 %